Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Offringa

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Vaccine|June 8, 2001
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimensS H van der Burg, K M Kwappenberg, T O'Neill, et al.
Seminars in Immunology|November 5, 1997
Activation or frustration of anti-tumor responses by T-cell-based immune modulationR E Toes, S P Schoenberger, E I van der Voort, et al.
Cell|November 17, 1989
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytesW M Kast, R Offringa, P J Peters, et al.
Molecular and Cellular Biology|November 1, 1990
Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor familyH van Dam, R Offringa, I Meijer, et al.
Cancer Research|July 29, 1998
Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopesT van Hall, N E van de Rhee, S P Schoenberger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogeneR E Toes, R Offringa, R J Blom, et al.
Cancer Research|July 29, 1998
Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APCS P Schoenberger, L E Jonges, R J Mooijaart, et al.
Immunotechnology : an International Journal of Immunological Engineering|November 1, 1996
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunityM E Ressing, R Offringa, R E Toes, et al.
Cancer Research|January 13, 2001
Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma modelM W Schreurs, A A Eggert, A J de Boer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common originT van Hall, J van Bergen, P A van Veelen, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Vaccine|June 8, 2001
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimensS H van der Burg, K M Kwappenberg, T O'Neill, et al.
Seminars in Immunology|November 5, 1997
Activation or frustration of anti-tumor responses by T-cell-based immune modulationR E Toes, S P Schoenberger, E I van der Voort, et al.
Cell|November 17, 1989
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytesW M Kast, R Offringa, P J Peters, et al.
Molecular and Cellular Biology|November 1, 1990
Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor familyH van Dam, R Offringa, I Meijer, et al.
Cancer Research|July 29, 1998
Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopesT van Hall, N E van de Rhee, S P Schoenberger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogeneR E Toes, R Offringa, R J Blom, et al.
Cancer Research|July 29, 1998
Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APCS P Schoenberger, L E Jonges, R J Mooijaart, et al.
Immunotechnology : an International Journal of Immunological Engineering|November 1, 1996
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunityM E Ressing, R Offringa, R E Toes, et al.
Cancer Research|January 13, 2001
Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma modelM W Schreurs, A A Eggert, A J de Boer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common originT van Hall, J van Bergen, P A van Veelen, et al.
Pageof 10